Identified in 1973, somatostatin (SST) is a cyclic hormone peptide with a short biological half-
life. Somatostatin receptors (SSTRs) are widely expressed in the whole body, with five …

Opinion statement Neuroendocrine neoplasms (NEN) are a heterogeneous group of
tumours derived from cells of neuroendocrine origin and can potentially arise everywhere in …

Purpose The widespread use of gallium-68-labelled somatostatin analogue (SSA) PET, the
current standard for somatostatin receptor (SSTR) imaging, is limited by practical and …

Abstract The aluminium-[18F] fluoride ([18F] AlF) radiolabelling method combines the
favourable decay characteristics of fluorine-18 with the convenience and familiarity of metal …

Purpose To provide practice guideline/procedure standards for diagnostics and therapy
(theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands …

Simple Summary Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) are the
most common neuroendocrine tumors, with the ability of overexpressing somatostatin …

Purpose A series of radiotracers targeting fibroblast activation protein (FAP) with great
pharmacokinetics have been developed for cancer diagnosis and therapy. Nevertheless, the …

Radiolabeled peptides have emerged as highly specific agents for targeting receptors
expressed in tumors for therapeutic and diagnostic purposes. Peptides developed for …

Background PET nuclides can have a considerable influence on the spatial resolution and
image quality of PET/CT scans, which can influence diagnostics in oncology, for example …

Simple Summary The use of positron emission tomography (PET) imaging in neuro-
oncological surgery is an exciting field with thriving perspectives. Increasing evidence exists …